Enhanced Inflammatory Reactivity in the Pathogenesis of Spondyloarthropathies

References

• Jacobs J C. Spondyloarthritis and enthesopathy. Current concepts in rheumatology. Arch Intern Med 1983; 143: 103–7
   PubMed Web of Science ®Google Scholar
• Aho K, Leirisalo-Repo M, Repo H. Reactive arthritis. Clin Rheum Dis 1985; 11: 25–40
   PubMedGoogle Scholar
• Ebringer A, Baines M, Ptaszynska T. Spondyloarthritis, HLA-B27 and Klebsiella. Immunol Rev 1985; 86: 101–16
   PubMed Web of Science ®Google Scholar
• Van Bohemen Ch G, Grumet F C, Zanen H C. Identification of HLA-B27MI and -M2 cross-reactive antigens in Klebsiella, Shigella, and Yersinia. Immunology 1984; 52: 607–10
   PubMed Web of Science ®Google Scholar
• Schwimmbeck P L, Yu D TY, Oldstone M BA. Autoantibodies to HLA B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter's syndrome. J Exp Med 1987; 1166: 173–81
   Google Scholar
• Stieglitz H, Fosmire S, Lipsky P. identification of a 2–Md plasmid from Shigella Aexneri associated with reactive arthritis. Arthritis Rheum 1989; 32: 937–46
   PubMedGoogle Scholar
• McGuigan L E, Geczy A F, Edmonds J P. The immunopathology of ankylosing spondylitis — A review. Semin Arthritis Rheum 1985; 15: 81–105
   PubMed Web of Science ®Google Scholar
• Geczy A F, McGuigan L E, Sullivan J S, Edmonds J P. Cytotoxic lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J Exp Med 1986; 164: 932–7
   PubMed Web of Science ®Google Scholar
• Russel A S. Klebsiella and ankylosing spondylitis. Clin Exp Rheumatol 1988; 6: 1–2
   PubMed Web of Science ®Google Scholar
• Fine J, Rutenberg S, Schweinburg F B. The role of reticuloendothelial system in hemorrhaggic shock. J Exp Med 1959; 110: 547–69
   PubMed Web of Science ®Google Scholar
• Serrander R, Magnusson Kihlström K-E., Sundqvist T. Acute yersinia infections in man increased intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scund J Infect Dis 1986; 18: 409–13
   PubMed Web of Science ®Google Scholar
• Smith M D, Gibson R A, Brooks P M. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1985; 12: 299–305
   PubMed Web of Science ®Google Scholar
• Hollander D, Vadheim C M, Brettholz E, Petersen G M, Delahunty T, Rotter J. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 1986; 105: 883–5
   PubMed Web of Science ®Google Scholar
• Foley-Nolan D, Coughlan R J, Sugrue D. Toxic shock syndrome associated arthropathy. Staphylococcus aureus: A further triggering event in reactive arthritis?. Ann Rheum Dis 1989; 48: 331–2
   PubMed Web of Science ®Google Scholar
• Lofgren R P, Tadlock L M, Soltis R D. Acute oligoarthritis association with Clostridium difficile pseudomembranous colitis. Arch Intern Med 1984; 144: 617–9
   PubMedGoogle Scholar
• Clarke J, Weiner S R, Bassett L W, Utsinger P D. Bypass disease. Clin Exp Rheumatol 1987; 5: 275–87
   PubMed Web of Science ®Google Scholar
• Moll J MH. Inflammatory bowel disease. Clin Rheum Dis 1985; 11: 87–111
   PubMedGoogle Scholar
• Van Bohemen Ch G., Nabbe A JJM, Grumet F C, Landheer J E, Dinant H J, Zanen H C. Lack of correlation between HLA-B27 like antigenic epitopes on Shigella flexneri and the occurrence of reactive arthritis. Clin Exp Immunol 1986; 65: 679–82
   PubMed Web of Science ®Google Scholar
• Winchester R, Bernstein D H, Fischer H D, Enlow R, Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern med 1987; 106: 19–26
   PubMed Web of Science ®Google Scholar
• Perussia B, Kobayashi M, Rossi M E, Anegon I, Trinchieri G. Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor. and granulocyte-macrohage colony-stimulating factor. J Immunol 1987; 138: 765–74
   PubMed Web of Science ®Google Scholar
• Segal A W. The molecular and cellular pathology of chronic granulomatous disease. Eur J Clin Invest 1988; 18: 433–43
   PubMed Web of Science ®Google Scholar
• Munford R S, Hall C L. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 1986; 234: 203–5
   PubMed Web of Science ®Google Scholar
• Valtonen V, Leirisalo M, Pentikänen P J., Räsänen T., Seppälä I, Larinkari U, Ranki M, Koskimies S., Malkamäki M, Mäkelä P H. Triggering infections in reactive arthritis. Ann Rheum Dis 1985; 44: 399–405
   PubMed Web of Science ®Google Scholar
• Weyand C, Goronzy J J. Immune response to Borrclia burgdoreri in patients with reactive arthritis. Arthritis Rheum 1989; 32: 1057–64
   PubMed Web of Science ®Google Scholar
• Wisnieski J J. Trauma and Reiter's syndrome: development of 'reactive' arthropathy in two patients following musculoskeletal injury. Ann Rheum Dis 1984; 43: 829–32
   PubMed Web of Science ®Google Scholar
• Blake D R, Merry P, Unsworth J, Kidd B L, Outhwaite J M, Ballard R, Morris C J, Gray L, Lunec J. Hypoxic- reperfusion injury in the inflamed human joint. Lancet 1989; i: 289–93
   Web of Science ®Google Scholar
• Schachter J, Barnes M G, Jones J P, Engelman E P., Meyer K F. Isolation of Bedsoniae from the oints of patients with Reiter's syndrome. Proc Soc Exp Biol Med 1966; 122: 283–5
   PubMed Web of Science ®Google Scholar
• Vilppula A H., Yli-Kerttula U I, Ahlroos A K, Terho P E. Chlamydia1 isolations and serology in Reiter's syndrome. Scand J Rheumatol 1981; 10: 181–5
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Ohno O, Yamasaki K, Ikuta S, Hirohata K. Arthritis presumably caused by chlamydia in Reiter syndrome. J Boric Joint Surg Am 1986; 68: 777–9
   PubMedGoogle Scholar
• Keat A, Thomas B, Dixey J, Osborn M, Sonnex C, Taylor-Robinson D. chlamydia trachomatis and reactive arthritis: the missing link. Lancer 1987; i: 72–4
   Google Scholar
• Schumacher H R, Jr., Magge S, Varghese Cherian P, Sleckman J, Rothfuss S, Clayburne G, Sieck M. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Arthritis Rheum 1988; 31: 937–46
   PubMed Web of Science ®Google Scholar
• Granfors K, Jalkanen S, Von Essen R, Lahesmaa-Rantala R, Isomäki O, Pekkola-Heino K, Merilahti-Palo R, Saario R, Isomäki H, Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 216–21
   PubMed Web of Science ®Google Scholar
• Granfors K, Jalkanen S, Lindberg A A, Mäki-Ikola O, von Essen R, Lahesmaa-Rantala R, Isomäki H, Saario R, Arnold W J, Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990; 335: 685–88
   PubMed Web of Science ®Google Scholar
• Hoogkamp-Korstanje J AA, de Koning J, Samsom J P. Incidence of human infection with Yersinia enterocolitica serotypes 03, 08, and 09 and the use of indirect immunofluorescence in diagnosis. J Infect Dis 1986; 153: 138–41
   PubMed Web of Science ®Google Scholar
• Hoogkam-Korstanje J AA, de Koning J, Heesemann J. Persistence of Yersinia enterocolitica in man. Infection 1988; 16: 81–5
   PubMed Web of Science ®Google Scholar
• Leirisalo M, Repo H, Tiilikainen A, Kosunen T U, Laitinen O. chemotaxis in yersinia arthritis HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum 1980; 23: 1036–44
   PubMed Web of Science ®Google Scholar
• Pease C T, Fordham J T, Currey H LF. Polymorphonuclear cell motility, ankylosing spondylitis. and HLA-B27. Ann Rheum Dis 1984; 43: 279–84
   PubMed Web of Science ®Google Scholar
• Pease C T, Fennell M, Brewerton D A. Polymorphonuclear leucocyte motility in men with ankylosing spondylitis. Ann Rheum Dis 1989; 48: 35–41
   PubMed Web of Science ®Google Scholar
• Koivuranta-Vaara P, Repo H, Leirisalo M, Kiistala U, Öterman T., Vapaatalo H. Enhanced neutrophil migration in vivo in HLA-B27 positive subjects. Ann Rheum Dis 1984; 43: 181–5
   PubMed Web of Science ®Google Scholar
• Repo H, Koivuranta-Vaara P, Leirisalo-Repo M. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced superoxide production correlates with late manifestations. Ann Rheum Dis 1988; 47: 452–7
   PubMed Web of Science ®Google Scholar
• Repo H, Leirisalo-Repo M, Skurnik M, Tiilikainen A. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis. Med Eiol 1984; 62: 91–4
   Google Scholar
• Miller C, Russell A S. The generation of superoxide anions by polymorphonuclear leucocytes from patients with ankylosing spondylitis in response to stimulant f-met-leu-phe. Clin Exp Rheumatol 1986; 4: 135–7
   PubMed Web of Science ®Google Scholar
• Koivuranla-Vaara P, Leirisalo-Repo M, Repo H. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. Ann Rheum Dis 1987; 46: 307–13
   PubMed Web of Science ®Google Scholar
• DeChatelet L R, Long G D, Shirley P S, Bass D A, Thomas M J, Henderson F W, Cohen M S. Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol 1982; 129: 1589–93
   PubMed Web of Science ®Google Scholar
• Ristokd M. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous yersinia arthritis. aPMIS 1989; 98: 125–30
   Web of Science ®Google Scholar
• Dahlgren C. Effects of extra- and intracellularly localized, chemoattractant-induced, oxygen radical production in neutrophils following modulation of conditions for ligand-receptor interaction. Inflammation 1988; 12: 335–49
   PubMed Web of Science ®Google Scholar
• Edwards S W. Luminol- and lucigenin-dependent chemiluminescence of neutrophils: role of degrdnulation. J Clin Lab Immunol 1987; 22: 35–9
   PubMedGoogle Scholar
• Feltelius N, Hallgren R, Venge P. Raised circulating levels of the osinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and influence of sulphasalazine treatment. Ann Rheum Dis 1987; 46: 403–7
   PubMed Web of Science ®Google Scholar
• Repo H, Leirisalo M, Tiilikainen A, Laitinen O. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA-B27 positive and negative sera. Arthritis Rheum 1982; 25: 655–61
   PubMed Web of Science ®Google Scholar
• Meri S, Partanen J, Leirisalo-Repo M, Repo H. Complement activation and HLA-B27. Ann Rheum Dis 1988; 47: 210–4
   PubMed Web of Science ®Google Scholar
• Le J, Vilcek J. Biology of disease. Tumor necrosis factor and interleukin I: Cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234–48
   PubMed Web of Science ®Google Scholar
• Wong G G, Clard S C. Multiple actions of interleukin 6 within a cytokine network. Immunol Today 1988; 9: 137–9
   PubMedGoogle Scholar
• Thelen M, Peveri P, Kernen P, Von Tscharner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEE J 1988; 2: 2702–6
   PubMed Web of Science ®Google Scholar
• Repo H., Jäättelä M., Leirisalo-Repo M, Hurme M. Production of tumour necrosis factor and interleukin I by monocytes of patients with previous yersinia arthritis. Clin Exp Immunol 1988; 72: 410–4
   PubMed Web of Science ®Google Scholar
• Speis T, Morton C C, Nedospasov S A, Fiers W, Pious D. Genes for the tumor necrosis factors α and β are linked to the human major histocompatibility complex. Proc Natl Acad Sci 1986; 83: 8699–702
   PubMed Web of Science ®Google Scholar